Captisol News and Activities

Presence

Headquarters: United States (USA)

Captisol is owned by Ligand Pharmaceuticals.


Ligand Pharmaceuticals is one of the...

Ligand Pharmaceuticals is a company listed under the stock ticker LGND (US).

Ligand Pharmaceuticals has 3 subsidiaries including Captisol, Channel Therapeutics and Pelthos Therapeutics.

They are in:

Acquisition, funding and merger involving Ligand Pharmaceuticals.

Executives

View the org chart displaying its 4 main executives

Most searched biographies at Captisol
Popular executive movements at Ligand Pharmaceuticals
  • Peter Renehan has joined the company as Vice President, Investments and Business Development  (posted on April 3 2026).
  • Lauren Hay who was Vice President, Strategic Planning and Investment Analytics, becomes Vice President of Portfolio Strategy and Investments  (posted on April 3 2026).
  • Lee Brown has joined the company as Vice President, Investments & Business Development  (posted on April 3 2026).

Create your alert
to follow the executive moves at Captisol.

News

Press releases by Captisol
Social media about Captisol

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.